JPH0233689B2 - - Google Patents

Info

Publication number
JPH0233689B2
JPH0233689B2 JP57165546A JP16554682A JPH0233689B2 JP H0233689 B2 JPH0233689 B2 JP H0233689B2 JP 57165546 A JP57165546 A JP 57165546A JP 16554682 A JP16554682 A JP 16554682A JP H0233689 B2 JPH0233689 B2 JP H0233689B2
Authority
JP
Japan
Prior art keywords
brain
disorders
organic
improving
diphenylmethane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57165546A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5955829A (ja
Inventor
Shizuo Kuryama
Mikio Saito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Original Assignee
Mitsubishi Kasei Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Kasei Corp filed Critical Mitsubishi Kasei Corp
Priority to JP57165546A priority Critical patent/JPS5955829A/ja
Priority to US06/530,247 priority patent/US4507322A/en
Priority to EP83109401A priority patent/EP0103897B1/en
Priority to IT22949/83A priority patent/IT1169837B/it
Priority to DE8383109401T priority patent/DE3369640D1/de
Publication of JPS5955829A publication Critical patent/JPS5955829A/ja
Priority to US06/637,285 priority patent/US4576966A/en
Publication of JPH0233689B2 publication Critical patent/JPH0233689B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP57165546A 1982-09-22 1982-09-22 脳内の器質性障害に起因する精神機能症状の改善・治療剤 Granted JPS5955829A (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP57165546A JPS5955829A (ja) 1982-09-22 1982-09-22 脳内の器質性障害に起因する精神機能症状の改善・治療剤
US06/530,247 US4507322A (en) 1982-09-22 1983-09-08 Pharmaceutical composition useful for improvement and/or treatment of mental symptoms caused by organic disorder in brain
EP83109401A EP0103897B1 (en) 1982-09-22 1983-09-21 Pharmaceutical composition useful for improvement and/or treatment of mental symptoms caused by organic disorder in brain
IT22949/83A IT1169837B (it) 1982-09-22 1983-09-21 Composizione farmaceutica utile per il miglioramento e/o il trattamento di sintomi mentali provocati da disturbi organici nel cervello
DE8383109401T DE3369640D1 (en) 1982-09-22 1983-09-21 Pharmaceutical composition useful for improvement and/or treatment of mental symptoms caused by organic disorder in brain
US06/637,285 US4576966A (en) 1982-09-22 1984-08-03 Treatment of mental symptoms caused by organic disorder in brain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57165546A JPS5955829A (ja) 1982-09-22 1982-09-22 脳内の器質性障害に起因する精神機能症状の改善・治療剤

Publications (2)

Publication Number Publication Date
JPS5955829A JPS5955829A (ja) 1984-03-31
JPH0233689B2 true JPH0233689B2 (enExample) 1990-07-30

Family

ID=15814427

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57165546A Granted JPS5955829A (ja) 1982-09-22 1982-09-22 脳内の器質性障害に起因する精神機能症状の改善・治療剤

Country Status (5)

Country Link
US (2) US4507322A (enExample)
EP (1) EP0103897B1 (enExample)
JP (1) JPS5955829A (enExample)
DE (1) DE3369640D1 (enExample)
IT (1) IT1169837B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0698390A1 (en) 1994-07-12 1996-02-28 Mitsubishi Chemical Corporation Use of bifemelane for the manufacture of a medicament for the treatment of hyperkinetic disorders

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2506376B2 (ja) * 1987-07-16 1996-06-12 三菱化学株式会社 ２−（４−メチルアミノブトキシ）ジフェニルメタン・塩酸塩の製造方法
US5547993A (en) * 1995-10-24 1996-08-20 Mitsubishi Chemical Corporation Therapeutic agent for glaucoma

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154070C (da) * 1975-06-19 1989-02-27 Mitsubishi Chem Ind Analogifremgangsmaade til fremstilling af 2-substituerede 1-(omega-aminoalkoxy)benzenderivater
JPS606349B2 (ja) * 1975-09-10 1985-02-18 三菱化成工業株式会社 ２―（ω‐アミノアルコキシ）ジフエニルメタン類

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0698390A1 (en) 1994-07-12 1996-02-28 Mitsubishi Chemical Corporation Use of bifemelane for the manufacture of a medicament for the treatment of hyperkinetic disorders

Also Published As

Publication number Publication date
US4507322A (en) 1985-03-26
IT8322949A0 (it) 1983-09-21
JPS5955829A (ja) 1984-03-31
EP0103897B1 (en) 1987-02-04
IT1169837B (it) 1987-06-03
DE3369640D1 (en) 1987-03-12
US4576966A (en) 1986-03-18
EP0103897A1 (en) 1984-03-28

Similar Documents

Publication Publication Date Title
JP2003525903A (ja) コリンエステラーゼ阻害剤の新規使用法
US20130150434A1 (en) Methods of using low-dose doxepin for the improvement of sleep
DE19523502A1 (de) Kappa-Opiatagonisten für entzündliche Darmerkrankungen
JP2022507533A (ja) 肺動脈性高血圧症および他疾患に関連する肺動脈性肺高血圧症の治療法
AU2006305309A1 (en) Pharmaceutical for protection of motor nerve in patient with amyotrophic lateral sclerosis
EP4606798A1 (en) Benzoisothiazole compound, and pharmaceutical composition and use thereof
CA3181902A1 (en) Methods for treating or preventing chronic kidney disease
JP3448869B2 (ja) 糖尿病性合併症の予防・治療剤
JPH0233689B2 (enExample)
EP0951907B1 (de) Verwendung von Moxonidin als Thermogenese stimulierend wirksames Arzneimittel
TWI289060B (en) Pharmaceutical composition for improving the recovery of post-stroke patients
CN106946866B (zh) 一种预防和治疗脑卒中的药物及其制备方法
EP2231603B1 (en) Substituted 3 -hydroxypyridines and pharmaceutical compositions thereof
WO1990011080A1 (en) Drug for improving brain function
WO2011058943A1 (ja) Ｍｃｈ ｒ１アンタゴニスト活性を有する化合物とｎｐｙ ｙ５受容体アンタゴニスト活性を有する化合物を組み合わせてなる医薬組成物
CN112457291B (zh) 苯并硫代吡喃酮类化合物的盐及其制备方法和用途
JP3450399B2 (ja) 血管新生阻害剤
EP1038526A1 (de) Behandlung von funktionellen Störungen der unteren Darmwege und einhergehenden visceralen Schmerzen mit Moxonidin
RU2834322C1 (ru) Соли бензотиопиранонового соединения, способ их получения и применения
TW201032805A (en) Pharmaceutical compositions comprising a compound having suppressive effect on nutrient digestion or absorption and a cyclohexanecarboxamide derivative
JPH0372468A (ja) トリアゾール化合物及びこれを含有する抗真菌剤
JPS5835186A (ja) ジカルボキシアミノチアゾール誘導体およびそれを含有する免疫調節組成物
JPH02288823A (ja) 筋弛緩剤
JPH10338634A (ja) 医薬組成物
JP2008184396A (ja) 神経損傷に起因する身体機能障害の予防及び治療のための医薬

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees